Page 73 - GPD-4-2

Gene & Protein in Disease X chromosome in sex-biased autoimmunity

of systemic lupus erythematosus. Proc Natl Acad Sci U S A. surface of patients with dry eye syndrome. Invest Ophthalmol
2009;106(15):6256-6261. Vis Sci. 2010;51(2):643-650.
doi: 10.1073/pnas.0901181106 doi: 10.1167/iovs.09-3425
116. Kaufman KM, Zhao J, Kelly JA, et al. Fine mapping of Xq28: 126. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of
Both MECP2 and IRAK1 contribute to risk for systemic the interferon-gamma-induced T cell-attracting chemokines,
lupus erythematosus in multiple ancestral groups. Ann interferon-gamma-inducible 10-kd protein (CXCL10) and
Rheum Dis. 2013;72(3):437-444. monokine induced by interferon-gamma (CXCL9), in the
salivary gland lesions of patients with Sjogren’s syndrome.
doi: 10.1136/annrheumdis-2012-201851
Arthritis Rheum. 2002;46(10):2730-2741.
117. Zhai Y, Xu K, Leng RX, et al. Association of interleukin-1
receptor-associated kinase (IRAK1) gene polymorphisms doi: 10.1002/art.10577
(rs3027898, rs1059702) with systemic lupus erythematosus in 127. Kim JW, Ahn MH, Jung JY, Suh CH, Han JH, Kim HA. Role
a Chinese Han population. Inflamm Res. 2013;62(6):555-560. of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in
the serum and minor salivary gland tissues of patients with
doi: 10.1007/s00011-013-0607-2
Sjogren’s syndrome. Clin Exp Med. 2024;24(1):133.
118. Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M.
Increased microRNA-146a/b, TRAF6 gene and decreased doi: 10.1007/s10238-024-01401-4
IRAK1 gene expressions in the peripheral mononuclear 128. Blokland SLM, Kislat A, Homey B, et al. Decreased
cells of patients with Sjogren’s syndrome. Immunol Lett. circulating CXCR3 CCR9 T helper cells are associated
+
+
2012;141(2):165-168. with elevated levels of their ligands CXCL10 and CCL25
in the salivary gland of patients with Sjogren’s syndrome
doi: 10.1016/j.imlet.2011.09.006
to facilitate their concerted migration. Scand J Immunol.
119. Balaton BP, Cotton AM, Brown CJ. Derivation of consensus 2020;91(3):e12852.
inactivation status for X-linked genes from genome-wide doi: 10.1111/sji.12852
studies. Biol Sex Differ. 2015;6:35.
129. Liao X, Pirapakaran T, Luo XM. Chemokines and chemokine
doi: 10.1186/s13293-015-0053-7
receptors in the development of lupus nephritis. Mediators
120. O’Driscoll DN, De Santi C, McKiernan PJ, McEneaney V, Inflamm. 2016;2016:6012715.
Molloy EJ, Greene CM. Expression of X-linked toll-like
receptor 4 signaling genes in female vs. male neonates. doi: 10.1155/2016/6012715
Pediatr Res. 2017;81(5):831-837. 130. Enghard P, Humrich JY, Rudolph B, et al. CXCR3 CD4 T
+
+
cells are enriched in inflamed kidneys and urine and provide
doi: 10.1038/pr.2017.2
a new biomarker for acute nephritis flares in systemic lupus
121. Pyfrom S, Paneru B, Knox JJ, et al. The dynamic epigenetic erythematosus patients. Arthritis Rheum. 2009;60(1):199-206.
regulation of the inactive X chromosome in healthy human doi: 10.1002/art.24136
B cells is dysregulated in lupus patients. Proc Natl Acad Sci
U S A. 2021;118(24):e2024624118. 131. Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R.
CD40, CD154, Bax and Bcl-2 expression in Sjogren’s syndrome
doi: 10.1073/pnas.2024624118
salivary glands: A putative anti-apoptotic role during its
122. Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell effector phases. Scand J Immunol. 2002;56(6):561-571.
Res. 2011;317(5):620-631.
doi: 10.1046/j.1365-3083.2002.01168.x
doi: 10.1016/j.yexcr.2010.12.017
132. Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM,
123. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Manoussakis MN. CD40 on salivary gland epithelial cells:
Lymphocyte-specific chemokine receptor CXCR3: High constitutive expression by cultured cells from Sjogren’s
Regulation, chemokine binding and gene localization. Eur J syndrome patients indicating their intrinsic activation. Clin
Immunol. 1998;28(11):3696-3705. Exp Immunol. 2002;127(2):386-392.
doi: 10.1002/(SICI)1521-4141(199811)28:11<3696:AID- doi: 10.1046/j.1365-2249.2002.01752.x
IMMU3696>3.0.CO;2-W
133. Van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc
124. Lacotte S, Brun S, Muller S, Dumortier H. CXCR3, Biol. 2000;67(1):2-17.
inflammation, and autoimmune diseases. Ann N Y Acad Sci. doi: 10.1002/jlb.67.1.2
2009;1173:310-317.
134. Kawabe T, Naka T, Yoshida K, et al. The immune responses
doi: 10.1111/j.1749-6632.2009.04813.x
in CD40-deficient mice: Impaired immunoglobulin class
125. Yoon KC, Park CS, You IC, et al. Expression of switching and germinal center formation. Immunity.
CXCL9, -10, -11, and CXCR3 in the tear film and ocular 1994;1(3):167-178.

Volume 4 Issue 2 (2025) 13 doi: 10.36922/gpd.8321